BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.91
-0.12 (-1.33%)
At close: Apr 2, 2026, 4:00 PM EDT
9.08
+0.17 (1.91%)
After-hours: Apr 2, 2026, 4:42 PM EDT
BBOT Market Cap
BBOT has a market cap or net worth of $713.09 million as of April 2, 2026. Its market cap has increased by 174.50% in one year.
Market Cap
713.09M
Enterprise Value
290.40M
1-Year Change
174.50%
Ranking
Category
Stock Price
$8.91
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $713.09M, an increase of 1,766.12%. That is a compound annual growth rate of 291.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 713.09M | -28.79% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 750.76M |
| MeiraGTx Holdings | 747.68M |
| SELLAS Life Sciences Group | 741.68M |
| Solid Biosciences | 736.95M |
| Relmada Therapeutics | 733.18M |
| Replimune Group | 694.44M |
| Arvinas | 693.98M |
| Design Therapeutics | 692.58M |